TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
RCEL

Avita Medical Ltd

Healthcare · Medical Devices

11.20$ +7.4% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Avita Medical Ltd (RCEL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 98.5% of the shares are freely tradable; institutional investors hold 17.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 17.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 98.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 9.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 31Mio.

Largest Shareholders

Institutions

Institutions RCEL
Name Stake (%) Shares Change (%) Date
Vanguard Capital Management, LLC 4.32 1,335,152 +0.0 03/31/2026
BlackRock Inc 3.66 1,133,126 +4.9 03/31/2026
Geode Capital Management, LLC 1.76 542,974 +13.3 03/31/2026
State Street Corp 1.39 429,022 +2.6 03/31/2026
Vanguard Fiduciary Trust Co 0.63 193,436 +0.0 03/31/2026
Northern Trust Corp 0.59 183,181 +12.1 03/31/2026
Morgan Stanley - Brokerage Accounts 0.51 157,621 +5.3 03/31/2026

Funds

Funds RCEL
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 3.10 958,401 +0.0 07/31/2026
Vanguard Institutional Extnd Mkt Idx Tr 1.14 351,113 +3.0 07/31/2026
Fidelity Extended Market Index 0.49 150,755 -5.1 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?